ReviewWorld journal of gastrointestinal pharmacology and therapeutics2026
Beyond the gut microbe: Rethinking infection, microbiome harmony, and the one-health continuum.
Review in World journal of gastrointestinal pharmacology and therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Emerging microbial discoveries have transformed infectious-disease science, yet detection alone does not equate to pathogenicity. Human health is mediated by complex microbiomes, and dysbiosis can convert commensals into opportunists, a concept captured by the "pathobiome". Across infectious-disease literature, gaps remain in integrating ecological context, host response, longitudinal data, and one-health perspectives. Misinterpretation of culture or sequencing results drives antimicrobial misuse, resistance, and ecological harm. We propose an eight-principle framework to distinguish pathogen from non-pathogen: (1) Clinical localization; (2) Temporal host response; (3) Exclusion of alternative sources; (4) Ecological context; (5) Host susceptibility; (6) Contamination assessment; (7) Transparent reporting of methods and quantitative thresholds; and (8) Ethical use of diagnostic technology. Adoption of this framework to any specialty, including gut, promotes accurate infection identification, stewardship, and transparency. Expanding perspective from the individual microbiome to planetary health, this approach aligns discovery with ecological and ethical responsibility, transforming infectious-disease practice from reactionary treatment to preservation of microbial harmony.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.